| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Otolaryngology | 13 | 2007 | 38 | 1.910 |
Why?
|
| Rhinitis | 14 | 2006 | 383 | 1.260 |
Why?
|
| Rhinitis, Allergic, Perennial | 6 | 2012 | 43 | 1.260 |
Why?
|
| Rhinitis, Allergic, Seasonal | 4 | 2012 | 22 | 1.200 |
Why?
|
| Sinusitis | 14 | 2004 | 432 | 1.130 |
Why?
|
| Hypersensitivity | 5 | 2014 | 52 | 1.050 |
Why?
|
| Immunotherapy | 5 | 2012 | 215 | 0.800 |
Why?
|
| Paranasal Sinus Neoplasms | 7 | 2001 | 23 | 0.720 |
Why?
|
| Allergens | 4 | 2010 | 54 | 0.620 |
Why?
|
| Head and Neck Neoplasms | 11 | 1998 | 561 | 0.550 |
Why?
|
| Skin Neoplasms | 6 | 2003 | 375 | 0.530 |
Why?
|
| Orbit | 6 | 2001 | 30 | 0.520 |
Why?
|
| Carcinoma, Basal Cell | 3 | 2003 | 40 | 0.520 |
Why?
|
| Immunologic Tests | 2 | 2014 | 9 | 0.510 |
Why?
|
| Otorhinolaryngologic Diseases | 4 | 2003 | 14 | 0.500 |
Why?
|
| Humans | 109 | 2014 | 68618 | 0.490 |
Why?
|
| Carcinoma, Squamous Cell | 6 | 2003 | 629 | 0.440 |
Why?
|
| Fellowships and Scholarships | 2 | 2004 | 127 | 0.420 |
Why?
|
| Orbital Neoplasms | 4 | 2001 | 21 | 0.400 |
Why?
|
| Laryngeal Neoplasms | 4 | 2003 | 47 | 0.390 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 5 | 2007 | 62 | 0.380 |
Why?
|
| Anti-Bacterial Agents | 7 | 2004 | 1026 | 0.370 |
Why?
|
| Education, Medical, Continuing | 2 | 2007 | 136 | 0.370 |
Why?
|
| Maxillary Sinus | 4 | 2006 | 12 | 0.360 |
Why?
|
| Desensitization, Immunologic | 2 | 2010 | 25 | 0.360 |
Why?
|
| Societies, Medical | 4 | 2005 | 403 | 0.360 |
Why?
|
| Bacterial Infections | 2 | 2002 | 163 | 0.350 |
Why?
|
| Skull Base Neoplasms | 3 | 2002 | 13 | 0.300 |
Why?
|
| Surgery, Plastic | 3 | 1997 | 14 | 0.300 |
Why?
|
| Paranasal Sinuses | 5 | 2000 | 165 | 0.300 |
Why?
|
| Allergy and Immunology | 2 | 2003 | 9 | 0.290 |
Why?
|
| Otitis Externa | 2 | 2006 | 14 | 0.290 |
Why?
|
| Internship and Residency | 5 | 2003 | 596 | 0.280 |
Why?
|
| Pharyngeal Neoplasms | 2 | 2003 | 8 | 0.280 |
Why?
|
| Maxillary Sinusitis | 1 | 2006 | 7 | 0.270 |
Why?
|
| Drug Therapy, Combination | 2 | 2004 | 649 | 0.260 |
Why?
|
| Paranasal Sinus Diseases | 4 | 1993 | 30 | 0.250 |
Why?
|
| Adrenal Cortex Hormones | 4 | 2004 | 186 | 0.250 |
Why?
|
| Osteoma | 1 | 2005 | 6 | 0.250 |
Why?
|
| Tongue Diseases | 1 | 2005 | 14 | 0.250 |
Why?
|
| Frontal Sinus | 2 | 2001 | 14 | 0.250 |
Why?
|
| Leukotriene Antagonists | 1 | 2004 | 13 | 0.250 |
Why?
|
| Tongue Neoplasms | 1 | 2005 | 29 | 0.250 |
Why?
|
| Publishing | 1 | 2005 | 89 | 0.230 |
Why?
|
| Anaphylaxis | 1 | 2003 | 43 | 0.220 |
Why?
|
| Orbital Diseases | 3 | 1997 | 21 | 0.220 |
Why?
|
| Nasal Polyps | 3 | 2004 | 184 | 0.220 |
Why?
|
| Sweat Gland Neoplasms | 1 | 2003 | 16 | 0.220 |
Why?
|
| Calcinosis | 1 | 2005 | 241 | 0.220 |
Why?
|
| Endoscopy | 3 | 2007 | 464 | 0.220 |
Why?
|
| Mouth Neoplasms | 2 | 2003 | 206 | 0.220 |
Why?
|
| Practice Guidelines as Topic | 2 | 2001 | 772 | 0.210 |
Why?
|
| Periodicals as Topic | 1 | 2005 | 158 | 0.210 |
Why?
|
| Immunoglobulin E | 3 | 2014 | 91 | 0.210 |
Why?
|
| Lymphatic Metastasis | 2 | 2003 | 274 | 0.200 |
Why?
|
| Skull Neoplasms | 3 | 1994 | 23 | 0.190 |
Why?
|
| Carcinoma | 2 | 1997 | 215 | 0.190 |
Why?
|
| United States | 14 | 2004 | 7367 | 0.180 |
Why?
|
| Respiratory Tract Infections | 1 | 2001 | 91 | 0.170 |
Why?
|
| Nose Neoplasms | 2 | 1991 | 25 | 0.170 |
Why?
|
| Optic Nerve | 3 | 1993 | 55 | 0.160 |
Why?
|
| Lymphatic System | 1 | 1998 | 5 | 0.160 |
Why?
|
| Mouth Floor | 1 | 1998 | 9 | 0.160 |
Why?
|
| Guideline Adherence | 1 | 2001 | 287 | 0.160 |
Why?
|
| Patient Care Team | 2 | 1994 | 311 | 0.150 |
Why?
|
| Combined Modality Therapy | 6 | 2003 | 951 | 0.150 |
Why?
|
| Acute Disease | 5 | 2006 | 658 | 0.150 |
Why?
|
| Neoplasm Staging | 4 | 2003 | 800 | 0.150 |
Why?
|
| Methods | 9 | 1994 | 156 | 0.150 |
Why?
|
| Tomography, X-Ray Computed | 11 | 2002 | 2324 | 0.140 |
Why?
|
| Glottis | 1 | 1997 | 17 | 0.140 |
Why?
|
| Adult | 27 | 2007 | 21403 | 0.140 |
Why?
|
| Nasolacrimal Duct | 2 | 1991 | 4 | 0.140 |
Why?
|
| Diagnosis, Differential | 6 | 2006 | 1140 | 0.140 |
Why?
|
| Education, Medical, Graduate | 2 | 1991 | 214 | 0.130 |
Why?
|
| Administration, Topical | 2 | 2006 | 111 | 0.130 |
Why?
|
| Craniocerebral Trauma | 3 | 1991 | 50 | 0.130 |
Why?
|
| Sleep Apnea Syndromes | 2 | 1985 | 40 | 0.130 |
Why?
|
| Fibroma | 2 | 1988 | 20 | 0.130 |
Why?
|
| Primary Health Care | 1 | 2001 | 703 | 0.130 |
Why?
|
| Patient Care | 2 | 2007 | 61 | 0.120 |
Why?
|
| Meningioma | 1 | 1995 | 54 | 0.120 |
Why?
|
| Neck | 2 | 1998 | 62 | 0.120 |
Why?
|
| Female | 29 | 2007 | 38074 | 0.120 |
Why?
|
| Exophthalmos | 1 | 1994 | 6 | 0.120 |
Why?
|
| Graves Disease | 1 | 1994 | 8 | 0.120 |
Why?
|
| Osteoma, Osteoid | 2 | 1985 | 5 | 0.120 |
Why?
|
| Basophils | 1 | 2014 | 57 | 0.120 |
Why?
|
| Carotid Artery Diseases | 2 | 1985 | 83 | 0.120 |
Why?
|
| Treatment Outcome | 8 | 2007 | 7029 | 0.120 |
Why?
|
| Postoperative Complications | 10 | 2007 | 1615 | 0.120 |
Why?
|
| Nasal Decongestants | 2 | 1999 | 7 | 0.120 |
Why?
|
| History, 19th Century | 2 | 2011 | 95 | 0.120 |
Why?
|
| Male | 28 | 2007 | 37321 | 0.110 |
Why?
|
| Universal Precautions | 1 | 1993 | 5 | 0.110 |
Why?
|
| Th2 Cells | 1 | 2012 | 48 | 0.110 |
Why?
|
| Occupational Diseases | 1 | 1993 | 68 | 0.110 |
Why?
|
| Chronic Disease | 7 | 2004 | 1330 | 0.100 |
Why?
|
| South Carolina | 4 | 2005 | 2752 | 0.100 |
Why?
|
| Orbital Fractures | 1 | 1991 | 5 | 0.100 |
Why?
|
| Burns, Inhalation | 1 | 1991 | 3 | 0.100 |
Why?
|
| Neck Injuries | 1 | 1991 | 17 | 0.100 |
Why?
|
| Facial Nerve Injuries | 1 | 1991 | 4 | 0.100 |
Why?
|
| Ear Protective Devices | 1 | 1991 | 2 | 0.100 |
Why?
|
| History, 18th Century | 1 | 2011 | 26 | 0.100 |
Why?
|
| History, Ancient | 1 | 2011 | 25 | 0.100 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2004 | 129 | 0.100 |
Why?
|
| Surgical Flaps | 2 | 2002 | 120 | 0.090 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2012 | 199 | 0.090 |
Why?
|
| Mohs Surgery | 2 | 2003 | 16 | 0.090 |
Why?
|
| Ethmoid Sinus | 3 | 1988 | 15 | 0.090 |
Why?
|
| Lymph Node Excision | 2 | 2003 | 91 | 0.090 |
Why?
|
| History, 20th Century | 2 | 2005 | 248 | 0.090 |
Why?
|
| Mycoses | 2 | 2002 | 60 | 0.090 |
Why?
|
| Hearing Loss, Noise-Induced | 1 | 1991 | 46 | 0.090 |
Why?
|
| Middle Aged | 16 | 2007 | 21147 | 0.090 |
Why?
|
| Injections, Subcutaneous | 1 | 2010 | 87 | 0.090 |
Why?
|
| Occupational Exposure | 1 | 1991 | 122 | 0.090 |
Why?
|
| Burns | 1 | 1991 | 83 | 0.090 |
Why?
|
| Ethmoid Bone | 4 | 1994 | 18 | 0.090 |
Why?
|
| Airway Obstruction | 3 | 1991 | 49 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2002 | 2223 | 0.090 |
Why?
|
| Medical Illustration | 1 | 1989 | 4 | 0.090 |
Why?
|
| Tympanic Membrane | 3 | 1986 | 25 | 0.090 |
Why?
|
| Hemangioma | 2 | 1987 | 51 | 0.080 |
Why?
|
| Aspergillosis | 1 | 1989 | 20 | 0.080 |
Why?
|
| Skin Tests | 3 | 1998 | 30 | 0.080 |
Why?
|
| Choanal Atresia | 1 | 1988 | 5 | 0.080 |
Why?
|
| Nasal Cavity | 3 | 1988 | 62 | 0.080 |
Why?
|
| Acoustic Impedance Tests | 3 | 1986 | 11 | 0.080 |
Why?
|
| Adolescent | 10 | 2002 | 8912 | 0.080 |
Why?
|
| Ear Canal | 3 | 1984 | 24 | 0.080 |
Why?
|
| Retrospective Studies | 8 | 2007 | 7277 | 0.080 |
Why?
|
| Fibrous Dysplasia, Polyostotic | 1 | 1987 | 3 | 0.080 |
Why?
|
| Fibrous Dysplasia of Bone | 1 | 1987 | 6 | 0.080 |
Why?
|
| Child | 8 | 2002 | 6405 | 0.070 |
Why?
|
| Infant | 6 | 2001 | 2891 | 0.070 |
Why?
|
| Competency-Based Education | 1 | 2007 | 32 | 0.070 |
Why?
|
| Radioallergosorbent Test | 2 | 1998 | 5 | 0.070 |
Why?
|
| Xeroderma Pigmentosum | 1 | 1987 | 3 | 0.070 |
Why?
|
| Food Hypersensitivity | 2 | 1998 | 20 | 0.070 |
Why?
|
| Medical Errors | 1 | 2007 | 80 | 0.070 |
Why?
|
| Benzethonium | 1 | 2006 | 1 | 0.070 |
Why?
|
| Acetic Acid | 1 | 2006 | 14 | 0.070 |
Why?
|
| Ear Diseases | 2 | 1986 | 37 | 0.070 |
Why?
|
| Propylene Glycols | 1 | 2006 | 16 | 0.070 |
Why?
|
| Exudates and Transudates | 1 | 2006 | 25 | 0.070 |
Why?
|
| Pituitary Neoplasms | 1 | 2007 | 52 | 0.070 |
Why?
|
| Respiratory Insufficiency | 1 | 1987 | 76 | 0.070 |
Why?
|
| Vision Disorders | 2 | 1985 | 94 | 0.070 |
Why?
|
| Drug Hypersensitivity | 1 | 2006 | 35 | 0.070 |
Why?
|
| Forecasting | 1 | 2007 | 277 | 0.070 |
Why?
|
| Curriculum | 2 | 2007 | 575 | 0.070 |
Why?
|
| Brain Neoplasms | 2 | 1994 | 371 | 0.070 |
Why?
|
| Epinephrine | 2 | 2003 | 103 | 0.070 |
Why?
|
| Child, Preschool | 5 | 2001 | 3187 | 0.070 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 1986 | 6 | 0.070 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 1986 | 15 | 0.070 |
Why?
|
| Algorithms | 2 | 2003 | 1196 | 0.070 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 1986 | 12 | 0.070 |
Why?
|
| Radiography | 5 | 1987 | 572 | 0.070 |
Why?
|
| Palate, Soft | 1 | 1985 | 12 | 0.070 |
Why?
|
| Steroids | 1 | 2006 | 84 | 0.070 |
Why?
|
| Oropharynx | 1 | 1985 | 20 | 0.070 |
Why?
|
| Drug Combinations | 1 | 2006 | 304 | 0.070 |
Why?
|
| Learning | 1 | 2007 | 186 | 0.070 |
Why?
|
| Branchioma | 1 | 1985 | 2 | 0.070 |
Why?
|
| Face | 1 | 1985 | 46 | 0.060 |
Why?
|
| Analgesics | 1 | 2006 | 118 | 0.060 |
Why?
|
| Medicine | 1 | 2005 | 52 | 0.060 |
Why?
|
| Specialization | 1 | 2005 | 66 | 0.060 |
Why?
|
| History, 21st Century | 1 | 2005 | 127 | 0.060 |
Why?
|
| HIV Infections | 1 | 1993 | 791 | 0.060 |
Why?
|
| Lacrimal Apparatus | 2 | 1988 | 9 | 0.060 |
Why?
|
| Anti-Infective Agents | 1 | 2006 | 166 | 0.060 |
Why?
|
| Aged | 10 | 2002 | 14862 | 0.060 |
Why?
|
| Cholesteatoma | 1 | 1984 | 4 | 0.060 |
Why?
|
| Carotid Arteries | 1 | 1984 | 110 | 0.060 |
Why?
|
| Amoxicillin-Potassium Clavulanate Combination | 1 | 2004 | 6 | 0.060 |
Why?
|
| Nasal Obstruction | 1 | 2004 | 34 | 0.060 |
Why?
|
| Noise | 2 | 1983 | 153 | 0.060 |
Why?
|
| Carotid Body Tumor | 1 | 1984 | 4 | 0.060 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 1984 | 3 | 0.060 |
Why?
|
| Mucocele | 1 | 1983 | 20 | 0.060 |
Why?
|
| Maxillary Sinus Neoplasms | 1 | 1983 | 3 | 0.060 |
Why?
|
| Administration, Intranasal | 1 | 2004 | 88 | 0.060 |
Why?
|
| Histamine | 1 | 2003 | 52 | 0.060 |
Why?
|
| Rhinoplasty | 2 | 1985 | 27 | 0.060 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2004 | 125 | 0.060 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2004 | 40 | 0.060 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2003 | 92 | 0.060 |
Why?
|
| Sleep Wake Disorders | 1 | 2004 | 94 | 0.060 |
Why?
|
| Cerebrospinal Fluid Otorrhea | 1 | 1983 | 15 | 0.060 |
Why?
|
| Ethics, Professional | 1 | 2003 | 8 | 0.050 |
Why?
|
| Surgical Procedures, Operative | 1 | 2004 | 124 | 0.050 |
Why?
|
| Respiratory Sounds | 1 | 1982 | 35 | 0.050 |
Why?
|
| Mandibular Neoplasms | 1 | 1982 | 16 | 0.050 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2003 | 189 | 0.050 |
Why?
|
| Clinical Competence | 1 | 2007 | 657 | 0.050 |
Why?
|
| United States Occupational Safety and Health Administration | 2 | 1993 | 2 | 0.050 |
Why?
|
| Schools, Medical | 1 | 1983 | 157 | 0.050 |
Why?
|
| Lymph Nodes | 2 | 1998 | 258 | 0.050 |
Why?
|
| Risk Factors | 3 | 2003 | 5731 | 0.050 |
Why?
|
| Sympathetic Nervous System | 1 | 1982 | 81 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 2004 | 222 | 0.050 |
Why?
|
| Drug Resistance, Microbial | 1 | 2002 | 70 | 0.050 |
Why?
|
| Diving | 1 | 1981 | 5 | 0.050 |
Why?
|
| Thyroid Neoplasms | 1 | 1982 | 68 | 0.050 |
Why?
|
| Guidelines as Topic | 1 | 2002 | 123 | 0.050 |
Why?
|
| Sports Medicine | 1 | 1981 | 22 | 0.050 |
Why?
|
| Maxillary Neoplasms | 1 | 1981 | 12 | 0.050 |
Why?
|
| Interprofessional Relations | 1 | 2003 | 188 | 0.050 |
Why?
|
| Adenoidectomy | 1 | 1981 | 51 | 0.050 |
Why?
|
| Carotid Artery, Internal | 1 | 1981 | 85 | 0.050 |
Why?
|
| Medical History Taking | 2 | 1999 | 94 | 0.050 |
Why?
|
| Physical Examination | 2 | 1999 | 152 | 0.050 |
Why?
|
| Virus Diseases | 1 | 2001 | 31 | 0.050 |
Why?
|
| Infant, Newborn | 4 | 1988 | 2455 | 0.050 |
Why?
|
| Hemodynamics | 1 | 2003 | 705 | 0.050 |
Why?
|
| Tonsillectomy | 1 | 1981 | 69 | 0.050 |
Why?
|
| Comorbidity | 1 | 2004 | 1426 | 0.040 |
Why?
|
| Communication | 1 | 2003 | 329 | 0.040 |
Why?
|
| Craniotomy | 2 | 1994 | 33 | 0.040 |
Why?
|
| Health Personnel | 1 | 2003 | 286 | 0.040 |
Why?
|
| Lipoma | 1 | 1979 | 24 | 0.040 |
Why?
|
| Follow-Up Studies | 3 | 2002 | 3259 | 0.040 |
Why?
|
| Dacryocystorhinostomy | 1 | 1979 | 5 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 1982 | 475 | 0.040 |
Why?
|
| Hemorrhage | 1 | 1981 | 328 | 0.040 |
Why?
|
| Lip Neoplasms | 1 | 1979 | 12 | 0.040 |
Why?
|
| Brachial Plexus | 1 | 1979 | 15 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2000 | 216 | 0.040 |
Why?
|
| Parotid Neoplasms | 1 | 1979 | 49 | 0.040 |
Why?
|
| Animals | 4 | 2012 | 20881 | 0.040 |
Why?
|
| Histamine H1 Antagonists | 1 | 1999 | 22 | 0.040 |
Why?
|
| Neurilemmoma | 1 | 1979 | 26 | 0.040 |
Why?
|
| Mouth Mucosa | 1 | 1979 | 51 | 0.040 |
Why?
|
| Abscess | 1 | 1979 | 37 | 0.040 |
Why?
|
| Laryngeal Diseases | 1 | 1979 | 22 | 0.040 |
Why?
|
| Lymph | 1 | 1998 | 8 | 0.040 |
Why?
|
| Chemoprevention | 1 | 1998 | 26 | 0.040 |
Why?
|
| Nasal Provocation Tests | 1 | 1998 | 2 | 0.040 |
Why?
|
| Inflammation | 1 | 2004 | 1030 | 0.040 |
Why?
|
| Respiratory Hypersensitivity | 1 | 1998 | 12 | 0.040 |
Why?
|
| Health Care Costs | 1 | 2001 | 346 | 0.040 |
Why?
|
| Skull Base | 1 | 1998 | 72 | 0.040 |
Why?
|
| Peripheral Nerves | 1 | 1997 | 22 | 0.040 |
Why?
|
| Eye Diseases | 1 | 1997 | 38 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 1999 | 201 | 0.040 |
Why?
|
| Laryngectomy | 1 | 1997 | 30 | 0.040 |
Why?
|
| Laser Therapy | 1 | 1997 | 54 | 0.040 |
Why?
|
| Optic Nerve Injuries | 2 | 1988 | 5 | 0.030 |
Why?
|
| Carbon Dioxide | 1 | 1997 | 78 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 1997 | 108 | 0.030 |
Why?
|
| Laryngoscopy | 1 | 1997 | 61 | 0.030 |
Why?
|
| Lip Diseases | 1 | 1996 | 8 | 0.030 |
Why?
|
| Nose Diseases | 1 | 1996 | 8 | 0.030 |
Why?
|
| Education, Continuing | 1 | 1996 | 28 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 1997 | 369 | 0.030 |
Why?
|
| Feeding Behavior | 1 | 1998 | 224 | 0.030 |
Why?
|
| Pressure | 3 | 1988 | 252 | 0.030 |
Why?
|
| Child Care | 1 | 1995 | 13 | 0.030 |
Why?
|
| Cysts | 1 | 1996 | 70 | 0.030 |
Why?
|
| Wounds, Nonpenetrating | 2 | 1988 | 131 | 0.030 |
Why?
|
| Cats | 3 | 1986 | 292 | 0.030 |
Why?
|
| Otitis Media | 1 | 1995 | 35 | 0.030 |
Why?
|
| Conjunctiva | 1 | 1994 | 16 | 0.030 |
Why?
|
| Paresthesia | 1 | 1994 | 8 | 0.030 |
Why?
|
| Diplopia | 1 | 1994 | 14 | 0.030 |
Why?
|
| Eye Movements | 1 | 1994 | 44 | 0.030 |
Why?
|
| Optic Neuritis | 1 | 1993 | 26 | 0.030 |
Why?
|
| Protective Devices | 1 | 1993 | 13 | 0.030 |
Why?
|
| Visual Acuity | 1 | 1994 | 236 | 0.030 |
Why?
|
| Protective Clothing | 1 | 1993 | 12 | 0.030 |
Why?
|
| Sterilization | 1 | 1993 | 29 | 0.030 |
Why?
|
| Embolization, Therapeutic | 2 | 1984 | 150 | 0.030 |
Why?
|
| Reoperation | 2 | 1984 | 467 | 0.020 |
Why?
|
| Cranial Nerve Diseases | 1 | 1991 | 14 | 0.020 |
Why?
|
| Maximum Allowable Concentration | 1 | 1991 | 5 | 0.020 |
Why?
|
| Facial Nerve | 1 | 1991 | 25 | 0.020 |
Why?
|
| Ear, Middle | 2 | 1983 | 32 | 0.020 |
Why?
|
| Fluid Therapy | 1 | 1991 | 59 | 0.020 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1991 | 46 | 0.020 |
Why?
|
| Osteotomy | 1 | 1991 | 46 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 1991 | 129 | 0.020 |
Why?
|
| Sepsis | 1 | 1993 | 233 | 0.020 |
Why?
|
| France | 1 | 1989 | 26 | 0.020 |
Why?
|
| Aspergillus flavus | 1 | 1989 | 3 | 0.020 |
Why?
|
| Etoposide | 1 | 1989 | 64 | 0.020 |
Why?
|
| Sphenoid Sinus | 1 | 1989 | 10 | 0.020 |
Why?
|
| Aspergillus fumigatus | 1 | 1989 | 27 | 0.020 |
Why?
|
| Microsurgery | 1 | 1989 | 46 | 0.020 |
Why?
|
| Fluorouracil | 1 | 1989 | 130 | 0.020 |
Why?
|
| Nasopharynx | 1 | 1988 | 7 | 0.020 |
Why?
|
| Cisplatin | 1 | 1989 | 192 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1991 | 446 | 0.020 |
Why?
|
| Cicatrix | 2 | 1986 | 60 | 0.020 |
Why?
|
| Skin | 1 | 1991 | 451 | 0.020 |
Why?
|
| Length of Stay | 1 | 1991 | 780 | 0.020 |
Why?
|
| Oxymetazoline | 1 | 1987 | 3 | 0.020 |
Why?
|
| Nerve Compression Syndromes | 1 | 1987 | 16 | 0.020 |
Why?
|
| Postoperative Care | 1 | 1988 | 163 | 0.020 |
Why?
|
| Optic Nerve Diseases | 1 | 1987 | 31 | 0.020 |
Why?
|
| Phenylephrine | 1 | 1987 | 61 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 1991 | 334 | 0.020 |
Why?
|
| Blood Pressure | 2 | 1984 | 1451 | 0.020 |
Why?
|
| Sex Factors | 2 | 1982 | 1266 | 0.020 |
Why?
|
| Eosinophils | 2 | 1997 | 60 | 0.020 |
Why?
|
| Myringoplasty | 1 | 1986 | 1 | 0.020 |
Why?
|
| Prospective Studies | 1 | 1994 | 3705 | 0.020 |
Why?
|
| Quality of Life | 1 | 1994 | 1515 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1989 | 468 | 0.020 |
Why?
|
| Hyperplasia | 1 | 1986 | 89 | 0.020 |
Why?
|
| Spasm | 1 | 1985 | 18 | 0.020 |
Why?
|
| Coma | 1 | 1985 | 17 | 0.020 |
Why?
|
| Time Factors | 2 | 1985 | 4655 | 0.020 |
Why?
|
| Cost of Illness | 2 | 1997 | 206 | 0.020 |
Why?
|
| Lidocaine | 1 | 1985 | 36 | 0.020 |
Why?
|
| Lymphoma | 1 | 1986 | 116 | 0.020 |
Why?
|
| Curettage | 1 | 1985 | 7 | 0.020 |
Why?
|
| Sarcoidosis | 1 | 1986 | 77 | 0.020 |
Why?
|
| Pilot Projects | 1 | 1989 | 1342 | 0.020 |
Why?
|
| Rupture, Spontaneous | 1 | 1984 | 21 | 0.020 |
Why?
|
| Constriction | 1 | 1984 | 37 | 0.020 |
Why?
|
| Ligation | 1 | 1984 | 83 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 1985 | 182 | 0.010 |
Why?
|
| Rupture | 2 | 1981 | 29 | 0.010 |
Why?
|
| Cartilage | 1 | 1984 | 51 | 0.010 |
Why?
|
| Carotid Artery, External | 1 | 1984 | 5 | 0.010 |
Why?
|
| Epistaxis | 1 | 2004 | 6 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 1984 | 145 | 0.010 |
Why?
|
| Bone Cysts | 1 | 1983 | 5 | 0.010 |
Why?
|
| Mastoid | 1 | 1983 | 20 | 0.010 |
Why?
|
| Neurofibroma | 1 | 1983 | 11 | 0.010 |
Why?
|
| Histiocytoma, Benign Fibrous | 1 | 1983 | 10 | 0.010 |
Why?
|
| Auditory Fatigue | 1 | 1983 | 1 | 0.010 |
Why?
|
| Pitch Perception | 1 | 1983 | 14 | 0.010 |
Why?
|
| Asthma | 2 | 1997 | 345 | 0.010 |
Why?
|
| Retropharyngeal Abscess | 1 | 1982 | 1 | 0.010 |
Why?
|
| Esthetics | 1 | 2002 | 18 | 0.010 |
Why?
|
| Cranial Fossa, Anterior | 1 | 2002 | 8 | 0.010 |
Why?
|
| Lymphadenitis | 1 | 1982 | 5 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 1984 | 296 | 0.010 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1982 | 36 | 0.010 |
Why?
|
| Preoperative Care | 1 | 1984 | 275 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 1986 | 442 | 0.010 |
Why?
|
| Edema | 1 | 1982 | 66 | 0.010 |
Why?
|
| Angiography | 1 | 1983 | 194 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1991 | 1173 | 0.010 |
Why?
|
| Glomerulonephritis | 1 | 1982 | 77 | 0.010 |
Why?
|
| Barium Sulfate | 1 | 1982 | 66 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 1982 | 172 | 0.010 |
Why?
|
| Decompression Sickness | 1 | 1981 | 1 | 0.010 |
Why?
|
| Barotrauma | 1 | 1981 | 3 | 0.010 |
Why?
|
| Carotid Artery Injuries | 1 | 1981 | 26 | 0.010 |
Why?
|
| Reference Values | 1 | 2002 | 579 | 0.010 |
Why?
|
| Embolism, Air | 1 | 1981 | 16 | 0.010 |
Why?
|
| Fluoroscopy | 1 | 1982 | 152 | 0.010 |
Why?
|
| Norepinephrine | 1 | 1982 | 276 | 0.010 |
Why?
|
| Recurrence | 1 | 1984 | 948 | 0.010 |
Why?
|
| Kidney Glomerulus | 1 | 1982 | 155 | 0.010 |
Why?
|
| Hypothermia | 1 | 1981 | 37 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1983 | 453 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2004 | 438 | 0.010 |
Why?
|
| Wound Healing | 1 | 2002 | 260 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 1981 | 236 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 1982 | 291 | 0.010 |
Why?
|
| Graft Survival | 1 | 2002 | 465 | 0.010 |
Why?
|
| Heart Rate | 1 | 1982 | 568 | 0.010 |
Why?
|
| Lacrimal Duct Obstruction | 1 | 1979 | 2 | 0.010 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 1979 | 4 | 0.010 |
Why?
|
| Contrast Media | 1 | 1982 | 595 | 0.010 |
Why?
|
| Larynx | 1 | 1979 | 49 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2002 | 1553 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 1986 | 2800 | 0.010 |
Why?
|
| Endoscopes | 1 | 1997 | 36 | 0.010 |
Why?
|
| Intradermal Tests | 1 | 1996 | 3 | 0.010 |
Why?
|
| Environmental Health | 1 | 1996 | 23 | 0.010 |
Why?
|
| Antigens | 1 | 1996 | 90 | 0.010 |
Why?
|
| Anti-Allergic Agents | 1 | 1996 | 27 | 0.010 |
Why?
|
| Child Day Care Centers | 1 | 1995 | 25 | 0.010 |
Why?
|
| Odds Ratio | 1 | 1995 | 880 | 0.010 |
Why?
|
| Incidence | 1 | 1995 | 1603 | 0.010 |
Why?
|
| Loudness Perception | 1 | 1983 | 13 | 0.000 |
Why?
|
| Psychoacoustics | 1 | 1983 | 33 | 0.000 |
Why?
|
| Stapes | 1 | 1978 | 7 | 0.000 |
Why?
|
| Acoustic Stimulation | 1 | 1978 | 206 | 0.000 |
Why?
|